KeyVibe-003: Randomized, double-blind, phase 3 study of first-line pembrolizumab with and without vibostolimab (anti-TIGIT) in patients with PD-L1-positive metastatic NSCLC

Please use this identifier to cite or link to this item: https://observatorio.fm.usp.br/handle/OPI/54411

Title:	KeyVibe-003: Randomized, double-blind, phase 3 study of first-line pembrolizumab with and without vibostolimab (anti-TIGIT) in patients with PD-L1-positive metastatic NSCLC
Authors:	CHO, Byoung Chul; JUERGENS, Rosalyn A.; CHENG, Ying; CASTRO JR., Gilberto de; ERMAN, Mustafa; BAUMAN, Jessica R.; TAKAHASHI, Toshiaki; SCHWARZENBERGER, Paul; LI, Chengxiang; PIETANZA, M. Catherine; YANG, James Chih-Hsin
Citation:	CANCER RESEARCH, v.82, n.12, suppl.S, 2022
Appears in Collections:	Comunicações em Eventos - FM/MDR Departamento de Radiologia - FM/MDR Comunicações em Eventos - HC/ICESP Instituto do Câncer do Estado de São Paulo - HC/ICESP Comunicações em Eventos - LIM/24 LIM/24 - Laboratório de Oncologia Experimental

Files in This Item:

There are no files associated with this item.